{"pageContent": "Background/aim: Androgen-androgen receptor (AR) signal is known as a powerful driver of prostate cancer progression. We previously reported the limitation of prostate-specific antigen (PSA) at diagnosis as a prognostic biomarker of prostate cancer. Although serum total testosterone (TT) level has been reported as a prognostic biomarker for prostate cancer, its usability is still controversial. We examined the potential and characteristics of TT as a biomarker.", "metaData": {"source": "Development of an integrated prostate cancer research information system\nhttps://pubmed.ncbi.nlm.nih.gov/16859581/"}}